Lugano Financial Advisors SA (LFA)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-150
Closed -$10.3K 184
2024
Q2
$10.3K Hold
150
0.01% 163
2024
Q1
$11K Hold
150
0.01% 155
2023
Q4
$12.2K Hold
150
0.01% 154
2023
Q3
$11.2K Hold
150
0.01% 146
2023
Q2
$11.6K Buy
+150
New +$12K 0.01% 160
2020
Q3
Sell
-2,760
Closed -$207K 116
2020
Q2
$207K Hold
2,760
0.22% 60
2020
Q1
$174K Hold
2,760
0.16% 71
2019
Q4
$179K Buy
+2,760
New +$180K 0.13% 74
2019
Q2
$186K Hold
2,760
0.12% 74
2019
Q1
$179K Hold
2,760
0.11% 74
2018
Q4
$213K Hold
2,760
0.15% 74
2018
Q3
$213K Buy
2,760
+1,544
+127% +$117K 0.15% 74
2018
Q2
$86K Buy
+1,216
New +$85.9K 0.08% 88

Other funds holding GILD

Lugano Financial Advisors SA (LFA)'s GILD Position: Q3 2024 in Review

Lugano Financial Advisors SA (LFA) sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 150 shares — an estimated $10.3K sold.

Lugano Financial Advisors SA (LFA) first reported a position in GILD in Q2 2018 and held it in 13 quarters. The position peaked at $213K in Q4 2018. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • Lugano Financial Advisors SA (LFA) reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
  • Lugano Financial Advisors SA (LFA) sold 150 Gilead Sciences shares in Q3 2024, an estimated $10.3K.
  • Lugano Financial Advisors SA (LFA) first reported a position in Gilead Sciences in Q2 2018 and held it in 13 quarters.
  • Lugano Financial Advisors SA (LFA)'s Gilead Sciences position peaked at $213K in Q4 2018.
  • 1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Lugano Financial Advisors SA (LFA)'s 13F filing for Q3 2024, filed 7 Nov 2024.